Cargando…

Pain perception description after advanced surface ablation

PURPOSE: The objective of this study was to characterize the evolution of ocular pain after advanced surface ablation (ASA) to improve strategies in postoperative pain management. METHODS: This was a multicenter, prospective, descriptive, cohort study. The inclusion criteria were healthy individuals...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobas, Eva M, Videla, Sebastián, Vázquez, Amanda, Fernández, Itziar, Maldonado, Miguel J, Pastor, José-Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391165/
https://www.ncbi.nlm.nih.gov/pubmed/28435216
http://dx.doi.org/10.2147/OPTH.S134542
_version_ 1783229227976359936
author Sobas, Eva M
Videla, Sebastián
Vázquez, Amanda
Fernández, Itziar
Maldonado, Miguel J
Pastor, José-Carlos
author_facet Sobas, Eva M
Videla, Sebastián
Vázquez, Amanda
Fernández, Itziar
Maldonado, Miguel J
Pastor, José-Carlos
author_sort Sobas, Eva M
collection PubMed
description PURPOSE: The objective of this study was to characterize the evolution of ocular pain after advanced surface ablation (ASA) to improve strategies in postoperative pain management. METHODS: This was a multicenter, prospective, descriptive, cohort study. The inclusion criteria were healthy individuals ≥18 years old receiving bilateral alcohol-assisted surface ablation with epithelial removal. Pain intensity was evaluated with the visual analog scale (VAS) and the numeric pain rating scale before and after surgery. Comorbidities (photophobia, burning, tearing, and foreign body sensation) and Hospital Anxiety and Depression (HAD) questionnaire were evaluated before and at 6 hours after surgery. Postoperative treatments included cold patch, topical cold antibiotics, topical steroids, and benzodiazepines. RESULTS: Thirty-two consecutive patients having similar profiles of postoperative pain evolution were included. At 0.5 hour after ASA, the pain score by VAS was 37±20 mm, and the maximum pain, 61±31 mm, occurred at 24 hours. Afterward, it decreased progressively until 72 hours after surgery (19±20 mm). Most patients (81%) scored >60 mm, and 44% required rescue medication. Among the comorbidities, all patients had photophobia and 84% had burning sensation. At 6 hours, the HAD score was 5.4±3.9, within the range of values considered as normal. CONCLUSION: Postoperative acute ocular pain after ASA showed a characteristic evolution over time. Recognition of the pattern could be important for improving the acceptance of ASA and for improving strategies in pain management in the postoperative period.
format Online
Article
Text
id pubmed-5391165
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-53911652017-04-21 Pain perception description after advanced surface ablation Sobas, Eva M Videla, Sebastián Vázquez, Amanda Fernández, Itziar Maldonado, Miguel J Pastor, José-Carlos Clin Ophthalmol Original Research PURPOSE: The objective of this study was to characterize the evolution of ocular pain after advanced surface ablation (ASA) to improve strategies in postoperative pain management. METHODS: This was a multicenter, prospective, descriptive, cohort study. The inclusion criteria were healthy individuals ≥18 years old receiving bilateral alcohol-assisted surface ablation with epithelial removal. Pain intensity was evaluated with the visual analog scale (VAS) and the numeric pain rating scale before and after surgery. Comorbidities (photophobia, burning, tearing, and foreign body sensation) and Hospital Anxiety and Depression (HAD) questionnaire were evaluated before and at 6 hours after surgery. Postoperative treatments included cold patch, topical cold antibiotics, topical steroids, and benzodiazepines. RESULTS: Thirty-two consecutive patients having similar profiles of postoperative pain evolution were included. At 0.5 hour after ASA, the pain score by VAS was 37±20 mm, and the maximum pain, 61±31 mm, occurred at 24 hours. Afterward, it decreased progressively until 72 hours after surgery (19±20 mm). Most patients (81%) scored >60 mm, and 44% required rescue medication. Among the comorbidities, all patients had photophobia and 84% had burning sensation. At 6 hours, the HAD score was 5.4±3.9, within the range of values considered as normal. CONCLUSION: Postoperative acute ocular pain after ASA showed a characteristic evolution over time. Recognition of the pattern could be important for improving the acceptance of ASA and for improving strategies in pain management in the postoperative period. Dove Medical Press 2017-04-07 /pmc/articles/PMC5391165/ /pubmed/28435216 http://dx.doi.org/10.2147/OPTH.S134542 Text en © 2017 Sobas et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Sobas, Eva M
Videla, Sebastián
Vázquez, Amanda
Fernández, Itziar
Maldonado, Miguel J
Pastor, José-Carlos
Pain perception description after advanced surface ablation
title Pain perception description after advanced surface ablation
title_full Pain perception description after advanced surface ablation
title_fullStr Pain perception description after advanced surface ablation
title_full_unstemmed Pain perception description after advanced surface ablation
title_short Pain perception description after advanced surface ablation
title_sort pain perception description after advanced surface ablation
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391165/
https://www.ncbi.nlm.nih.gov/pubmed/28435216
http://dx.doi.org/10.2147/OPTH.S134542
work_keys_str_mv AT sobasevam painperceptiondescriptionafteradvancedsurfaceablation
AT videlasebastian painperceptiondescriptionafteradvancedsurfaceablation
AT vazquezamanda painperceptiondescriptionafteradvancedsurfaceablation
AT fernandezitziar painperceptiondescriptionafteradvancedsurfaceablation
AT maldonadomiguelj painperceptiondescriptionafteradvancedsurfaceablation
AT pastorjosecarlos painperceptiondescriptionafteradvancedsurfaceablation